Google Loses €4.1B EU Antitrust Appeal; SoftBank to Launch US Neocloud

Key Takeaways

  • Alphabet’s Google (GOOGL) lost its final appeal against a record €4.125 billion ($4.67 billion) EU antitrust fine related to its Android operating system.
  • SoftBank Group (SFTBY) announced the establishment of SB Neo to launch "neocloud" services in the U.S. by fiscal year 2027, leveraging a 10-gigawatt AI infrastructure.
  • UBS lowered its year-end gold forecast to $5,000/oz (from previous higher targets), citing persistent headwinds from elevated real interest rates and a strong U.S. dollar.
  • Roche (RHHBY) reported that its experimental lung-cancer drug divarasib outperformed existing therapies from Amgen and Mirati in a late-stage clinical trial.
  • UK business morale slumped to its lowest level since late 2022 as the ongoing conflict with Iran continues to drive up energy and transportation costs.

Tech & Antitrust: Google’s Record Fine Upheld

Alphabet’s Google (GOOGL) has reached the end of the legal road in its battle with European regulators. The European Court of Justice upheld a €4.125 billion fine, confirming that the tech giant used its Android mobile operating system to illegally cement its search engine dominance. The court agreed with the European Commission's 2018 finding that Google forced manufacturers to pre-install Google Search and Chrome as a condition for using the Play Store.

While the fine was slightly reduced from the original €4.34 billion in a 2022 lower court ruling, it remains the largest antitrust penalty in EU history. Legal analysts suggest this final verdict reinforces the EU's aggressive stance on "gatekeeper" platforms and may set a precedent for ongoing Digital Markets Act (DMA) investigations.

SoftBank Targets US AI Infrastructure

SoftBank Group (SFTBY) and its telecom unit, SoftBank Corp., are expanding their AI ambitions to the United States. The companies will establish SB Neo, a subsidiary 51% owned by the telecom unit, to provide "neocloud" services. These services will offer the massive computing resources required for large-scale AI model training and inference to major U.S. enterprises and hyperscalers.

The venture will utilize SoftBank’s developing 10-gigawatt-scale energy and AI infrastructure. SoftBank plans to launch these services in the U.S. during the fiscal year ending March 31, 2028. This move follows the May 2026 launch of a beta GPU cloud service in Japan, signaling Masayoshi Son's commitment to leading the "AI revolution" through physical infrastructure.

Commodities & Forex: Gold Forecasts and Yen Volatility

UBS analysts have adjusted their outlook for gold, cutting the year-end forecast to $5,000/oz. Despite gold's status as a safe-haven asset during the Iran conflict, the bank noted that "markets are rediscovering the concept of opportunity cost" as real interest rates remain elevated. While the structural bull market is not considered over, the bank warned that a stronger U.S. dollar and rising Treasury yields will cap near-term gains.

In the currency markets, the U.S. Dollar experienced a sudden swing against the Japanese Yen, sliding 0.61% to 161.61 before stabilizing. The volatility comes amid high-stakes speculation regarding potential intervention by Japanese authorities. Meanwhile, Spain reported a net employment increase of 92.5K for June, significantly outperforming the previous month's 63.7K, even as unemployment fell by 28.7K.

Healthcare: Roche’s Breakthrough in Lung Cancer

Roche (RHHBY) announced positive results from a late-stage trial for its drug candidate, divarasib. The study showed that the drug outperformed current market leaders Amgen (AMGN) and Mirati Therapeutics in treating advanced lung cancer. Divarasib met both primary and secondary objectives, showing "meaningful improvements" in overall survival and progression-free survival.

The Swiss pharmaceutical giant intends to submit this data to global health authorities immediately. The success of divarasib is seen as a critical win for Roche’s oncology pipeline, which has faced pressure from biosimilar competition in recent years.

Geopolitical Impact: UK Morale and Trade Diplomacy

The ICAEW Business Confidence Monitor revealed that UK business morale has hit a three-year low. The survey of 1,000 accountants found that the war with Iran has pushed input prices up by 4.1%, leading to a sharp slowdown in hiring and investment. Over 57% of firms expect to raise their own prices in the coming year to offset soaring energy and shipping costs caused by the closure of the Strait of Hormuz.

On the diplomatic front, China’s Ministry of Commerce (MOFCOM) has invited EU Trade Commissioner Maros Sefcovic to visit Beijing this fall. The invitation follows the first meeting of the EU-China Trade and Investment Consultations, aimed at balancing a trade relationship strained by subsidies and export controls on critical minerals. Both sides have set an October deadline to deliver tangible results on trade frictions.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Scroll to Top